Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1282 A 839977Summary: P2X7 antagonist,potent and selective
- B1609 Aclidinium BromideSummary: LAMAs antagonist
- B1198 CisaprideTarget: Voltage-gated Potassium (KV) Channels|5-HT4 ReceptorSummary: 5-HT4 receptor agonist
- B1183 EscitalopramSummary: Serotonin reuptake inhibitor
- B2238 Escitalopram OxalateSummary: Selective 5-HT reuptake inhibitor
- B2256 SB742457Summary: 5-HT6 receptor antagonist,highly selective and high affinity
- B1272 FosaprepitantSummary: Neurokinin-1 antagonist
- B2145 Fosaprepitant dimeglumine saltTarget: Neurokinin receptorSummary: Neurokinin-1 antagonist
- B2099 HaloperidolSummary: Antipsychotic drug
- B1242 Haloperidol hydrochlorideSummary: Antipsychotic drug